ArticleThe American journal of case reports2025
Successful Treatment of a 42-Year-Old Man with Concurrent Anti-Glomerular Basement Membrane Disease and Anti-Phospholipase A2 Receptor Antibody-Positive Membranous Nephropathy: A Case Report.
Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Anti-glomerular basement membrane (anti-GBM) disease is an autoimmune disease mediated by deposit of antibodies to collagen type IV in glomerular and alveolar basement membranes. Membranous nephropathy (MN) is characterized by thickening of the glomerular capillary walls due to immune complex deposition. Anti-GBM disease can occur in conjunction with a second disease. However, simultaneous presentation of anti-GBM disease with MN has rarely been described. Here, we present a case of a 42-year-old man with combined anti-GBM disease and anti-phospholipase A2 receptor (PLA2R) antibody-positive membranous nephropathy. CASE REPORT A 42-year-old man was admitted due to acute kidney injury and proteinuria. Serum anti-GBM antibody was positive and the patient was diagnosed with anti-GBM disease without alveolar hemorrhage on day 2. Double-filtration plasmapheresis (DFPP) was performed starting on day 3, and intravenous methylprednisolone and cyclophosphamide were administrated. Kidney biopsy was performed on day 24 and demonstrated co-existence of anti-GBM disease and PLA2R antibody-positive MN. After discharge, the patient continued to receive oral corticosteroid and serial injections of cyclophosphamide over a course of 6 months. His kidney function recovered and MN reached partial remission. CONCLUSIONS We report the case of a 42-year-old man with concurrent anti-GBM disease and PLA2R antibody-positive MN. Early diagnosis and prompt treatment with a combined regimen of corticosteroid, cyclophosphamide, and DFPP were essential factors in the patient's successful recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.